SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on September 28, 2004. The filing reports the consolidated financial results for the first quarter ended August 29, 2004. The report incorporates a press release (Exhibit 99.1) by reference.
Note: The request metadata lists "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION".
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is referenced but not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the announcement of the first-quarter results.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risks, contingencies, or unusual items. Such information is presumed to be in the referenced press release.
Investor Verification Checklist
- Verify the specific revenue and net income figures for the quarter ended August 29, 2004, by reviewing Exhibit 99.1 (Press Release).
- Confirm the company name discrepancy between the request metadata (Lifecore Biomedical) and the filing (Landec Corporation).
- Review the press release for any forward-looking statements or guidance not present in the 8-K summary text.
- Check for any material changes in financial condition or operations detailed in the full press release.